Gene therapy Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Gene therapy

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: wave3rules	5/30/2007 10:38:58 AM
	of 319

NRLS ---- Huge news, this stock is basically UNKNOWN NRLS: Data Published re Spinal Stem Cells Restoring Normal Function in Rats By Fain Hughes, fhughes@knobias.com Researchers reported online in the journal, NEUROSCIENCE, that three rats paralyzed due to spinal ischemia returned to near normal ambulatory function six weeks after having received human spinal stem cells (hSSCs) developed by Neuralstem, Inc. (NRLS). Three other rats, while not able to stand up two months after treatment, showed significant improvement in the mobility of all three lower extremity joints and increased muscle tone. In all the grafted animals, the majority of transplanted hSSCs cells survived and became mature neurons. The study was conducted at the University of California at San Diego. Ischemic Spastic Paraplegia (ISP) is a painful form of extreme spasticity and rigidity that causes permanent and untreatable loss of motor function and paralysis. In humans, ISP can result fr om surgery to repair aortic aneurysms.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next